Combating Parkinson’s Disease
The Alfred Family Foundation is focused on working on a global initiative towards finding a cure for Parkinson’s disease (PD). We value our partnership with our Brazilian counterparts and all the hard work we have put in by continually working on funding towards finding a cure for this disease and engaging all who are connected to the Parkinson's community. We are dedicated to providing support to individuals and families affected by Parkinson's disease through support groups, education, awareness, and the support of research. We will also focus most of our attention and resources towards research and science education organizations committed to improving the health and enhancing the lives of patients battling Parkinson’s disease (PD).
Parkinson’s Disease (PD) is a movement disorder which produces slowing of physical movement, tremor and muscle rigidity. Though not considered fatal, PD does affect adults of all ages. In late stage cases, disability or death may result as a consequence of choking, pneumonia or series falls.
Hyperbaric Oxygen Therapy (HBO-T) is considered a very effective therapy for conditions such as Autism, Cerebral Palsy, MS, Parkinson's, healing of wounds, immune deficiency and much more.
Each patient’s response to any therapy will be unique. The relative duration of benefit of HBO-T for each patient will vary; for example ranging between one and five months. Nearly all PD patients demonstrated marked improvements in their general well-being and a reduction in tremors. The combination of pure oxygen and increase of atmospheric pressure contributes to accelerated healing and wellness. Patients will not have swollen joints nor hardened muscles anymore because the pressurized oxygen treatments took that swelling and forced it to go away. The reduction of symptoms suffered by patients contributes to increases overall wellness and reduction of pain and fatigue.
Hyperbaric Oxygen Therapy For Parkinson's Disease and Crohn's Disease
Hyperbaric oxygen therapy produces many healing functions throughout the body. The system delivers help to people through an oxygen enriched environment delivered by high-pressure air that is 100 percent pure. There are five benefits to using hyperbaric oxygen therapy. People have regained the use of motor skills which were damaged or lost after motor vehicle accidents when they underwent a series of hyperbaric oxygen treatments. Since the inception of hyperbaric oxygen therapy, there has been a notable improvement in mental processes.
This form of treatment has helped many patients that suffer from Parkinson's disease and Crohn's disease. Children that are afflicted with autism have achieved better concentration skills and better motor responses after they have spent one to two hours a day in the hyperbaric chamber over a period of a few months. People that suffer from chronic pain have noticed considerable relief after only one treatment in the hyperbaric chamber and of those, many came out of the treatments feeling better than they have in years. The benefits of using hyperbaric oxygen therapy go on. The immune system is bolstered by the regeneration of white and red blood cells because of the pure oxygen environment. The white blood cells are responsible for fighting any type of infection with the body on a cellular level. The red bloods cells are responsible for delivering oxygen to all of the bodily organs.
The oxygen-enriched environment has helped repair cell damage in many instances. Many doctors will encourage surgery patients to take advantage of treatments before they leave the hospital due to the therapeutic healing qualities of the treatments. People that undergo hyperbaric oxygen therapy achieve an overall feeling of healthy rejuvenation. They will also no longer feel depressed, or feel anxiety in any way. Frequent travelers will recover faster from flying on longer trips when treatments are used regularly at home. From the use people will notice relief from stiffness in the joints, and in most cases, they will not have swollen joints anymore because the pressurized oxygen treatments took that swelling and forced it to go away.
Hyperbaric oxygen therapy chambers are available for rent through local vendors. These oxygen therapy systems for home use can be rented on a month-to-month basis or bought outright by anyone that wants to benefit from them. Patients feel relief from many ailments after undergoing only one treatment in a hyperbaric oxygen therapy chamber. The Food and Drug Administration has endorsed hyperbaric oxygen therapy as a viable treatment for a large number of maladies. Hyperbaric oxygen therapies promote healing to all parts of the body and increase the growth of cells on all levels. This therapy will improve people's quality of life and their health.
Hyperbaric Oxygen Chamber Therapy helps Autism, Cerebral Palsy, MS, Parkinson's, Athletic Performing, healing of wounds, used as immune defense and much more. Visit our site at http://www.balancedhealthtoday.com Hyperbaric Oxygen Chamber Articles to learn more about our lowest market priced single and double chambers.
Article Source: http://EzineArticles.com/?expert=Paul_S_Fitzgerald
Advanced Hyperbaric Recovery – Hyperbaric Oxygen Therapy of Marin
http://hyperbaricoxygentherapy.com/conditions/investigational/parkinsons
5 patients with a history of Parkinson’s Disease (PD) were treated with Hyperbaric Oxygen Therapy (HBOT) for 1 hour at 1.5-2.0 ATA. All 5 patients reported a decrease in tremors and an improvement in general well-being. The patients under went an initial course of 10 treatments and were allowed to continue treatment as needed until they perceived a plateau in benefit. The treatment benefit appeared sustained for approximately 1-5 months, and was re-established following additional HBOT. There were no complications. HBOT may be a safe and effective treatment option for patients with PD.
PD is a progressive neurological disorder affecting at least 500,000 people in the United States. Parkinsonian Syndrome (PS) includes the idiopathic or typical PD which accounts for 85% of PS cases, neuroleptic-induced which accounts for 7-9% of PS and is reversible, and other types such as progressive supra nuclear palsy, multiple systems atrophy, corticobasal degeneration, vascular, toxins, and recurrent head trauma, all accounting for less than 10% of cases.
It has been demonstrated that even early stage PD exhibits a subnormal response to hypoxia. A discrepancy in ventilatory response to isocapnic, progressive hypoxic rebreathing in PD patients under minor and severe hypoxia was felt to be due to a dysfunction in chemoreception. The reduction in aveolar ventilation could not be attributed to mechanical restriction of lung function, and was unrelated to whether or not the patient was being treated with dopaminergic drugs.
Case 1:
This physician’s 86 year old mother with a 15-year history of PD and tremors at rest, bradykinesia, sleep disturbance, and depression taking 5 medications for PD underwent a course of 10 HBOT at 1.5 ATA. She reported an improvement in well-being and was observed to have a decrease in tremors. She underwent an additional 3 HBOT at 1.5 ATA. The beneficial effects of the treatment appeared to be sustained over the course of the next 4 months.
Case 2:
This 75 year old former corporate vice president with a 6 year history of PD taking dopaminergic drugs with resting tremors, difficulty with balance, and insomnia underwent 20 HBOT at 1.5 ATA and 3 treatments at 1.75 ATA. There was a significant improvement in tremors, balance, and insomnia, which has been maintained for 5 months. The tremors began to return, and the patient underwent 5 additional HBOT treatments with an improvement in symptoms.
Case 3:
This 63 year old former fire fighter with a 6 year history of PD like symptoms diagnosed with PD 4 years ago had discontinued his dopaminergic agents, but continued taking amantadine for his tremors without effect. He underwent 30 HBOT at 2.0 ATA and had a complete resolution of his right hand tremor, which has been maintained for the last 5 months.
Case 4:
This 69 year old practicing physician with a 3 year history of PD on dopaminergic medication had discontinued driving and reported difficulty in writing, episodes of rigidity, and always feeling “washed out”. After one HBOT treatment at 1.5 ATA, he reported feeling like “his own self again”, and after 7 treatments resumed driving. The treatment benefit appeared to last for 24 to 48 hours- the end point of the benefit strongly related to stress experienced at work. The patient underwent 13 additional HBOT treatments at 2.0 ATA (20 treatments total), and he reported a complete resolution of symptoms for one month. The “washed out” feeling returned and after undergoing an additional 2 HBOT treatments, he again felt “well”.
HBOT is a safe, easily administered, and relatively inexpensive treatment. K.H. Holbach reported that HBOT treatment at 1.5 ATA resulted in a balanced cerebral glucose metabolism, which indicated an improved oxygenation and energy production of the injured brain. In this preliminary study to determine if HBOT could play a role in treatment of PD, patients were treated, depending on the severity of their symptoms, from 1.5-2.0 ATA. The treatment ATA and the number of treatments were determined by the patient symptoms in relation to their subjective perceived benefit of treatment and the observations of the patient’s spouses or care givers. The positive preliminary results reported in this small group of patients may be due to a placebo effect. A prospective study using a constant ATA and objective assessment of effectiveness should now be performed to further evaluate the role of HBOT in the treatment of PD.
Print 